ELISA
Heart Dysfunction Insights Drawn From Age-Related Cardiomyocyte Mutations
Researchers used single-cell whole-genome sequencing to track somatic point mutations in heart cardiomyocytes in samples from infants to elderly individuals.
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications.
Biodesix Prices $72M IPO
Shares of the Boulder, Colorado-based firm will begin trading on the Nasdaq today under ticker symbol "BDSX" at $18 per share.
The firm uses a miniaturized, bead-based-ELISA format to multiplex hundreds to thousands of immunoassays rapidly and without antibody cross-reactivity.